Galectin Therapeutics Inc - balanço patrimonial (NASDAQ:GALT) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Total assets 29.6 M41.83 M21.29 M28.2 M17.5 M19.53 M Total liabilities 5.41 M39.21 M53.48 M88.44 M120.56 M145.73 M Total equity 22.47 M893 K-33.92 M-61.96 M-104.79 M-127.92 M Total liabilities & shareholders' equities 29.6 M41.83 M21.29 M28.2 M17.5 M19.53 M Total debt —8 000———— Net debt —-39.64 M————

Notícias

Galectin Therapeutics nomeia neurocirurgião de Johns Hopkins para o conselho

Galectin Therapeutics appoints Johns Hopkins neurosurgeon to board

Galectin Therapeutics Inc. (GALT) Discusses Updated Results for Belapectin in Treatment of MASH Cirrhosis and Portal Hypertension Transcript

Diretor da Galectin Therapeutics, Marc Rubin, renuncia ao conselho

Galectin Therapeutics director Marc Rubin resigns from board

CFO da Galectin Therapeutics vende ações no valor de US$ 233 mil

Galectin Therapeutics CFO sells $233k in shares

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

oracle, micron tech among market cap stock movers on friday

Ações da Galectin Therapeutics despencam após feedback da FDA sobre medicamento

Galectin Therapeutics stock plummets after FDA feedback on drug

FDA provides feedback on Galectin’s belapectin development program